

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of skeletal muscle contraction (GO:0014819) | 9.37572001 |
| 2 | negative regulation of cell aging (GO:0090344) | 8.83122919 |
| 3 | GDP-mannose metabolic process (GO:0019673) | 8.64058148 |
| 4 | protein carboxylation (GO:0018214) | 8.31187733 |
| 5 | peptidyl-glutamic acid carboxylation (GO:0017187) | 8.31187733 |
| 6 | DNA strand renaturation (GO:0000733) | 8.24407802 |
| 7 | cellular response to ATP (GO:0071318) | 8.00872960 |
| 8 | regulation of synapse structural plasticity (GO:0051823) | 7.84676581 |
| 9 | regulation of cytokine production involved in inflammatory response (GO:1900015) | 7.40914740 |
| 10 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 7.29598871 |
| 11 | adenosine receptor signaling pathway (GO:0001973) | 7.04238049 |
| 12 | negative regulation of cell killing (GO:0031342) | 6.97654160 |
| 13 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 6.97654160 |
| 14 | positive regulation of gamma-delta T cell activation (GO:0046645) | 6.94392227 |
| 15 | positive thymic T cell selection (GO:0045059) | 6.91428261 |
| 16 | granulocyte differentiation (GO:0030851) | 6.44776604 |
| 17 | regulation of gamma-delta T cell differentiation (GO:0045586) | 6.42876982 |
| 18 | transepithelial transport (GO:0070633) | 6.29612813 |
| 19 | lens fiber cell differentiation (GO:0070306) | 6.29298460 |
| 20 | positive T cell selection (GO:0043368) | 6.14545920 |
| 21 | meiotic chromosome segregation (GO:0045132) | 6.08238360 |
| 22 | G-protein coupled purinergic nucleotide receptor signaling pathway (GO:0035589) | 5.98259359 |
| 23 | negative T cell selection (GO:0043383) | 5.93057556 |
| 24 | negative thymic T cell selection (GO:0045060) | 5.87518763 |
| 25 | regulation of gamma-delta T cell activation (GO:0046643) | 5.70596530 |
| 26 | detection of light stimulus involved in sensory perception (GO:0050962) | 5.50071404 |
| 27 | detection of light stimulus involved in visual perception (GO:0050908) | 5.50071404 |
| 28 | semaphorin-plexin signaling pathway (GO:0071526) | 5.43057970 |
| 29 | purinergic nucleotide receptor signaling pathway (GO:0035590) | 5.34307927 |
| 30 | thymic T cell selection (GO:0045061) | 5.31129969 |
| 31 | positive regulation of heat generation (GO:0031652) | 5.09364294 |
| 32 | phosphatidylglycerol biosynthetic process (GO:0006655) | 5.04305894 |
| 33 | estrogen biosynthetic process (GO:0006703) | 4.89081537 |
| 34 | negative regulation of translation involved in gene silencing by miRNA (GO:0035278) | 4.86693822 |
| 35 | negative regulation of translation, ncRNA-mediated (GO:0040033) | 4.86693822 |
| 36 | regulation of translation, ncRNA-mediated (GO:0045974) | 4.86693822 |
| 37 | proline biosynthetic process (GO:0006561) | 4.85673557 |
| 38 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 4.82158127 |
| 39 | T cell selection (GO:0045058) | 4.80833618 |
| 40 | negative regulation of interleukin-8 production (GO:0032717) | 4.76227433 |
| 41 | positive regulation of protein kinase C signaling (GO:0090037) | 4.71784043 |
| 42 | regulation of isotype switching to IgG isotypes (GO:0048302) | 4.70072301 |
| 43 | adenine nucleotide transport (GO:0051503) | 4.43819558 |
| 44 | leukocyte aggregation (GO:0070486) | 4.38578800 |
| 45 | sensory perception of taste (GO:0050909) | 4.37637706 |
| 46 | regulation of phospholipid biosynthetic process (GO:0071071) | 4.37491098 |
| 47 | response to ATP (GO:0033198) | 4.37123281 |
| 48 | negative regulation of erythrocyte differentiation (GO:0045647) | 4.33740431 |
| 49 | T cell migration (GO:0072678) | 4.29604764 |
| 50 | protein insertion into membrane (GO:0051205) | 4.27310221 |
| 51 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.27221920 |
| 52 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.27221920 |
| 53 | sulfur amino acid catabolic process (GO:0000098) | 4.22523089 |
| 54 | UV protection (GO:0009650) | 4.18170286 |
| 55 | purine ribonucleotide transport (GO:0015868) | 4.17749712 |
| 56 | purinergic receptor signaling pathway (GO:0035587) | 4.11276193 |
| 57 | B cell receptor signaling pathway (GO:0050853) | 4.07453709 |
| 58 | rRNA methylation (GO:0031167) | 4.06348788 |
| 59 | sphingomyelin metabolic process (GO:0006684) | 4.05961089 |
| 60 | type B pancreatic cell proliferation (GO:0044342) | 4.02978867 |
| 61 | regulation of cell aging (GO:0090342) | 3.98448174 |
| 62 | rRNA modification (GO:0000154) | 3.93140303 |
| 63 | G-protein coupled purinergic receptor signaling pathway (GO:0035588) | 3.89729972 |
| 64 | T cell receptor signaling pathway (GO:0050852) | 3.88490463 |
| 65 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.86899551 |
| 66 | sphingosine metabolic process (GO:0006670) | 3.85664304 |
| 67 | NIK/NF-kappaB signaling (GO:0038061) | 3.81712440 |
| 68 | cardiolipin metabolic process (GO:0032048) | 3.76246628 |
| 69 | endocytic recycling (GO:0032456) | 3.72309905 |
| 70 | negative regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045736) | 3.70261146 |
| 71 | folic acid metabolic process (GO:0046655) | 3.63037875 |
| 72 | ncRNA 3-end processing (GO:0043628) | 3.62819165 |
| 73 | mitochondrion distribution (GO:0048311) | 3.61507043 |
| 74 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.61231906 |
| 75 | proline metabolic process (GO:0006560) | 3.60913583 |
| 76 | regulation of heat generation (GO:0031650) | 3.60462795 |
| 77 | response to interleukin-15 (GO:0070672) | 3.57133697 |
| 78 | peptidyl-glutamic acid modification (GO:0018200) | 3.56121709 |
| 79 | nucleotide-sugar biosynthetic process (GO:0009226) | 3.55381431 |
| 80 | antigen receptor-mediated signaling pathway (GO:0050851) | 3.54148467 |
| 81 | diol metabolic process (GO:0034311) | 3.53906571 |
| 82 | phosphatidylethanolamine biosynthetic process (GO:0006646) | 3.53816433 |
| 83 | histone H3-K4 trimethylation (GO:0080182) | 3.52525152 |
| 84 | negative regulation of mRNA splicing, via spliceosome (GO:0048025) | 3.51202881 |
| 85 | positive regulation of gene expression, epigenetic (GO:0045815) | 3.48746179 |
| 86 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.46225358 |
| 87 | cell migration in hindbrain (GO:0021535) | 3.44066897 |
| 88 | histone H4-K5 acetylation (GO:0043981) | 3.42571342 |
| 89 | histone H4-K8 acetylation (GO:0043982) | 3.42571342 |
| 90 | purine nucleotide transport (GO:0015865) | 3.38050362 |
| 91 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.37193084 |
| 92 | protein retention in ER lumen (GO:0006621) | 3.36489062 |
| 93 | regulation of translation in response to stress (GO:0043555) | 3.36084249 |
| 94 | phosphate ion homeostasis (GO:0055062) | 3.35675687 |
| 95 | trivalent inorganic anion homeostasis (GO:0072506) | 3.35675687 |
| 96 | cilium or flagellum-dependent cell motility (GO:0001539) | 3.33541367 |
| 97 | urinary tract smooth muscle contraction (GO:0014848) | 3.33138266 |
| 98 | cellular anion homeostasis (GO:0030002) | 3.31437401 |
| 99 | regulation of histone H3-K27 methylation (GO:0061085) | 3.27837944 |
| 100 | DNA deamination (GO:0045006) | 3.27285244 |
| 101 | negative regulation of innate immune response (GO:0045824) | 3.23720639 |
| 102 | positive regulation of histone deacetylation (GO:0031065) | 3.22418680 |
| 103 | positive regulation of isotype switching (GO:0045830) | 3.22058308 |
| 104 | purine deoxyribonucleotide catabolic process (GO:0009155) | 3.20699941 |
| 105 | viral transcription (GO:0019083) | 3.20159141 |
| 106 | negative regulation of RNA splicing (GO:0033119) | 3.12181437 |
| 107 | regulation of B cell differentiation (GO:0045577) | 3.11161380 |
| 108 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.10841188 |
| 109 | positive regulation of granulocyte differentiation (GO:0030854) | 3.10652382 |
| 110 | folic acid transport (GO:0015884) | 3.10569241 |
| 111 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.09633338 |
| 112 | cellular response to interleukin-15 (GO:0071350) | 3.09255860 |
| 113 | positive regulation of TOR signaling (GO:0032008) | 3.09092204 |
| 114 | DNA replication checkpoint (GO:0000076) | 3.09043740 |
| 115 | phosphatidylethanolamine metabolic process (GO:0046337) | 3.07298253 |
| 116 | negative regulation of toll-like receptor signaling pathway (GO:0034122) | 3.06478575 |
| 117 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 3.06280655 |
| 118 | tRNA modification (GO:0006400) | 3.05946186 |
| 119 | adaptation of signaling pathway (GO:0023058) | 3.03047094 |
| 120 | interferon-gamma production (GO:0032609) | 3.02687263 |
| 121 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.01801684 |
| 122 | DNA duplex unwinding (GO:0032508) | 3.01033671 |
| 123 | regulation of isotype switching (GO:0045191) | 3.00763027 |
| 124 | tolerance induction (GO:0002507) | 3.00402997 |
| 125 | grooming behavior (GO:0007625) | 2.99292396 |
| 126 | melanin biosynthetic process (GO:0042438) | 2.98064704 |
| 127 | histone H3-K4 methylation (GO:0051568) | 2.97991030 |
| 128 | positive regulation of interleukin-2 production (GO:0032743) | 2.95366216 |
| 129 | negative regulation of tumor necrosis factor production (GO:0032720) | 2.94731944 |
| 130 | histone phosphorylation (GO:0016572) | 2.94239777 |
| 131 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 2.92222215 |
| 132 | translational termination (GO:0006415) | 2.91910439 |
| 133 | DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 cla | 2.91331879 |
| 134 | histone H4-K16 acetylation (GO:0043984) | 2.90678835 |
| 135 | phosphate ion transmembrane transport (GO:0035435) | 2.88174953 |
| 136 | negative regulation of glycoprotein biosynthetic process (GO:0010561) | 2.87124793 |
| 137 | regulation of protein kinase A signaling (GO:0010738) | 2.86995115 |
| 138 | base-excision repair, AP site formation (GO:0006285) | 2.86165886 |
| 139 | regulation of T cell receptor signaling pathway (GO:0050856) | 2.85881016 |
| 140 | negative regulation of tumor necrosis factor superfamily cytokine production (GO:1903556) | 2.85066378 |
| 141 | modulation by virus of host process (GO:0019054) | 2.84500192 |
| 142 | DNA geometric change (GO:0032392) | 2.83399411 |
| 143 | positive regulation of DNA recombination (GO:0045911) | 2.82662056 |
| 144 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.82490369 |
| 145 | oligosaccharide catabolic process (GO:0009313) | 2.81070477 |
| 146 | ribosomal small subunit assembly (GO:0000028) | 2.80659713 |
| 147 | sphingolipid catabolic process (GO:0030149) | 2.79498975 |
| 148 | dolichol-linked oligosaccharide biosynthetic process (GO:0006488) | 2.76329428 |
| 149 | T cell costimulation (GO:0031295) | 2.75833359 |
| 150 | nucleoside transmembrane transport (GO:1901642) | 2.74650069 |
| 151 | hematopoietic stem cell differentiation (GO:0060218) | 2.74162627 |
| 152 | melanin metabolic process (GO:0006582) | 2.74149491 |
| 153 | positive regulation of megakaryocyte differentiation (GO:0045654) | 2.73275505 |
| 154 | negative regulation of mRNA processing (GO:0050686) | 2.72511037 |
| 155 | positive regulation of RNA splicing (GO:0033120) | 2.72463047 |
| 156 | regulation of response to interferon-gamma (GO:0060330) | 2.72168054 |
| 157 | lymphocyte costimulation (GO:0031294) | 2.71913676 |
| 158 | DNA damage response, signal transduction resulting in transcription (GO:0042772) | 2.71761915 |
| 159 | positive regulation of protein deacetylation (GO:0090312) | 2.71703446 |
| 160 | regulation of interferon-gamma-mediated signaling pathway (GO:0060334) | 2.71416030 |
| 161 | sphingoid metabolic process (GO:0046519) | 2.68047868 |
| 162 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 2.67727250 |
| 163 | lymphocyte migration (GO:0072676) | 2.67023667 |
| 164 | heme transport (GO:0015886) | 2.66947551 |
| 165 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 2.66700002 |
| 166 | T cell homeostasis (GO:0043029) | 2.65867107 |
| 167 | translational elongation (GO:0006414) | 2.65469175 |
| 168 | regulation of cholesterol metabolic process (GO:0090181) | 2.65366429 |
| 169 | regulation of hydrogen peroxide metabolic process (GO:0010310) | 2.65059945 |
| 170 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.64139291 |
| 171 | sodium ion export (GO:0071436) | 2.63937529 |
| 172 | mRNA cleavage (GO:0006379) | 2.63617267 |
| 173 | regulation of interleukin-2 production (GO:0032663) | 2.62467255 |
| 174 | membrane tubulation (GO:0097320) | 2.60826187 |
| 175 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.60257281 |
| 176 | negative regulation of T cell receptor signaling pathway (GO:0050860) | 2.58854642 |
| 177 | regulation of ARF GTPase activity (GO:0032312) | 2.57431775 |
| 178 | negative regulation of antigen receptor-mediated signaling pathway (GO:0050858) | 2.54998762 |
| 179 | regulation of RNA splicing (GO:0043484) | 2.54885710 |
| 180 | Peyers patch development (GO:0048541) | 2.54567607 |
| 181 | mucosal-associated lymphoid tissue development (GO:0048537) | 2.54567607 |
| 182 | regulation of defense response to virus by virus (GO:0050690) | 2.53673654 |
| 183 | negative regulation of necroptotic process (GO:0060546) | 2.51445604 |
| 184 | regulation of alternative mRNA splicing, via spliceosome (GO:0000381) | 2.50869514 |
| 185 | entrainment of circadian clock by photoperiod (GO:0043153) | 2.50359760 |
| 186 | negative regulation of histone methylation (GO:0031061) | 2.50348896 |
| 187 | positive regulation of B cell differentiation (GO:0045579) | 2.50054664 |
| 188 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 2.49412091 |
| 189 | regulation of histone H3-K4 methylation (GO:0051569) | 2.47827124 |
| 190 | phagocytosis, recognition (GO:0006910) | 2.47215758 |
| 191 | mannose metabolic process (GO:0006013) | 2.46903251 |
| 192 | snRNA metabolic process (GO:0016073) | 2.46140655 |
| 193 | intracellular estrogen receptor signaling pathway (GO:0030520) | 2.45443356 |
| 194 | maturation of SSU-rRNA (GO:0030490) | 2.44417382 |
| 195 | peptidyl-lysine trimethylation (GO:0018023) | 2.44004221 |
| 196 | T cell differentiation (GO:0030217) | 2.43949858 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MYC_22102868_ChIP-Seq_BL_Human | 4.25545312 |
| 2 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.51917140 |
| 3 | VDR_21846776_ChIP-Seq_THP-1_Human | 3.30164907 |
| 4 | TCF7_22412390_ChIP-Seq_EML_Mouse | 2.55346097 |
| 5 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.46932449 |
| 6 | KDM2B_26808549_Chip-Seq_DND41_Human | 2.46557493 |
| 7 | MAF_26560356_Chip-Seq_TH1_Human | 2.43496663 |
| 8 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.43202156 |
| 9 | CIITA_25753668_ChIP-Seq_RAJI_Human | 2.42531027 |
| 10 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 2.40138745 |
| 11 | UTX_26944678_Chip-Seq_JUKART_Human | 2.35336086 |
| 12 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 2.29381395 |
| 13 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 2.21994895 |
| 14 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 2.21685712 |
| 15 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.18614620 |
| 16 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.15083357 |
| 17 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.10320194 |
| 18 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.10149373 |
| 19 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 2.09770804 |
| 20 | LXR_22292898_ChIP-Seq_THP-1_Human | 2.09736197 |
| 21 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.07798978 |
| 22 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 2.06035246 |
| 23 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 2.00429305 |
| 24 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.99632919 |
| 25 | MAF_26560356_Chip-Seq_TH2_Human | 1.93242968 |
| 26 | MYB_26560356_Chip-Seq_TH2_Human | 1.90020743 |
| 27 | MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 1.87266953 |
| 28 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.86553884 |
| 29 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.83279264 |
| 30 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.82252804 |
| 31 | * SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.81943954 |
| 32 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.80749335 |
| 33 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.80305725 |
| 34 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.79760877 |
| 35 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 1.79487580 |
| 36 | MYB_26560356_Chip-Seq_TH1_Human | 1.79429446 |
| 37 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.78704688 |
| 38 | * CTCF_27219007_Chip-Seq_Bcells_Human | 1.78553624 |
| 39 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.78093566 |
| 40 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 1.76499552 |
| 41 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.75625105 |
| 42 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.74426689 |
| 43 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.74042148 |
| 44 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.73728068 |
| 45 | P68_20966046_ChIP-Seq_HELA_Human | 1.72312265 |
| 46 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.67950343 |
| 47 | * FOXP1_21924763_ChIP-Seq_HESCs_Human | 1.67062768 |
| 48 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.64486677 |
| 49 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.64460310 |
| 50 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.64363217 |
| 51 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.61403350 |
| 52 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.60399940 |
| 53 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.59976079 |
| 54 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.59619335 |
| 55 | SPI1_23127762_ChIP-Seq_K562_Human | 1.59520952 |
| 56 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.58421095 |
| 57 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.57719974 |
| 58 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.57240458 |
| 59 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.56897832 |
| 60 | * DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.55912727 |
| 61 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.55004159 |
| 62 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.54652872 |
| 63 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.51547148 |
| 64 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.50683257 |
| 65 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.49331322 |
| 66 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.48386290 |
| 67 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.47867638 |
| 68 | SPI1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.47569986 |
| 69 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.44814419 |
| 70 | * CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.44555714 |
| 71 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.44529328 |
| 72 | * CTCF_20526341_ChIP-Seq_ESCs_Human | 1.43648693 |
| 73 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.42048776 |
| 74 | * XRN2_22483619_ChIP-Seq_HELA_Human | 1.41913212 |
| 75 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.41516124 |
| 76 | * GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.39724695 |
| 77 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.38175299 |
| 78 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.37781352 |
| 79 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.36898303 |
| 80 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.35941018 |
| 81 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.34507005 |
| 82 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.34400230 |
| 83 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.33408875 |
| 84 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.33312556 |
| 85 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.32280925 |
| 86 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 1.30750191 |
| 87 | ETS1_21867929_ChIP-Seq_TH2_Mouse | 1.26717800 |
| 88 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 1.26049944 |
| 89 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.25424731 |
| 90 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.25160361 |
| 91 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.25145237 |
| 92 | ATF3_27146783_Chip-Seq_COLON_Human | 1.24987631 |
| 93 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.24947858 |
| 94 | * SMC4_20622854_ChIP-Seq_HELA_Human | 1.22917763 |
| 95 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.22765014 |
| 96 | * CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.22014844 |
| 97 | FLI1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.21963294 |
| 98 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.21377390 |
| 99 | PHF8_20622854_ChIP-Seq_HELA_Human | 1.21047968 |
| 100 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.20806553 |
| 101 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.19295314 |
| 102 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.18947897 |
| 103 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 1.17799246 |
| 104 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.17395257 |
| 105 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.17015560 |
| 106 | SA1_27219007_Chip-Seq_Bcells_Human | 1.15399799 |
| 107 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.14747947 |
| 108 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.14683917 |
| 109 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.13809973 |
| 110 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.11874639 |
| 111 | * CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.11481668 |
| 112 | KDM2B_26808549_Chip-Seq_K562_Human | 1.11347343 |
| 113 | JARID1B-DAIN_22020125_ChIP-Seq_ESCs_Mouse | 1.10828011 |
| 114 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.10576310 |
| 115 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.09711806 |
| 116 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.09663728 |
| 117 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.09402683 |
| 118 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.08019667 |
| 119 | PKCTHETA_26484144_Chip-Seq_BREAST_Human | 1.07779795 |
| 120 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.07542531 |
| 121 | CTCF_21964334_Chip-Seq_Bcells_Human | 1.07253862 |
| 122 | TFAP2A_17053090_ChIP-ChIP_MCF-7_Human | 1.07076092 |
| 123 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.06570698 |
| 124 | P300_27268052_Chip-Seq_Bcells_Human | 1.06424794 |
| 125 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.05614690 |
| 126 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.03796468 |
| 127 | * ERA_21632823_ChIP-Seq_H3396_Human | 1.03633104 |
| 128 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.03514082 |
| 129 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.02112670 |
| 130 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.01883545 |
| 131 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 1.01862899 |
| 132 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.01835649 |
| 133 | * RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.01309107 |
| 134 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 1.00897902 |
| 135 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.00694892 |
| 136 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.00504618 |
| 137 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.00213485 |
| 138 | SOX11_23321250_ChIP-ChIP_Z138-A519-JVM2_Human | 1.00142635 |
| 139 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 0.99104418 |
| 140 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.98930830 |
| 141 | * RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.98902757 |
| 142 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 0.98286106 |
| 143 | FOXP3_21729870_ChIP-Seq_TREG_Human | 0.98267442 |
| 144 | TP63_22573176_ChIP-Seq_HFKS_Human | 0.97932839 |
| 145 | * NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.97835526 |
| 146 | GATA1_19941826_ChIP-Seq_K562_Human | 0.96518181 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005171_absent_coat_pigmentation | 7.35181996 |
| 2 | MP0001986_abnormal_taste_sensitivity | 5.48073531 |
| 3 | MP0003763_abnormal_thymus_physiology | 4.13924290 |
| 4 | MP0008875_abnormal_xenobiotic_pharmacok | 3.56268592 |
| 5 | MP0001661_extended_life_span | 3.54057290 |
| 6 | MP0003136_yellow_coat_color | 3.47147925 |
| 7 | MP0005083_abnormal_biliary_tract | 3.26222242 |
| 8 | MP0005671_abnormal_response_to | 3.26191721 |
| 9 | MP0000751_myopathy | 3.17151603 |
| 10 | MP0000685_abnormal_immune_system | 3.11643458 |
| 11 | MP0002653_abnormal_ependyma_morphology | 2.73700200 |
| 12 | MP0005330_cardiomyopathy | 2.54085392 |
| 13 | MP0001188_hyperpigmentation | 2.40302517 |
| 14 | MP0002398_abnormal_bone_marrow | 2.38897411 |
| 15 | MP0001800_abnormal_humoral_immune | 2.37869781 |
| 16 | MP0002234_abnormal_pharynx_morphology | 2.33273228 |
| 17 | MP0000750_abnormal_muscle_regeneration | 2.32812327 |
| 18 | MP0008961_abnormal_basal_metabolism | 2.30178762 |
| 19 | MP0003866_abnormal_defecation | 2.29578461 |
| 20 | MP0000703_abnormal_thymus_morphology | 2.16818006 |
| 21 | MP0002420_abnormal_adaptive_immunity | 2.15146107 |
| 22 | MP0005058_abnormal_lysosome_morphology | 2.13575962 |
| 23 | MP0002160_abnormal_reproductive_system | 2.09832705 |
| 24 | MP0001819_abnormal_immune_cell | 2.08563429 |
| 25 | MP0002396_abnormal_hematopoietic_system | 2.07461732 |
| 26 | MP0001756_abnormal_urination | 2.07105170 |
| 27 | MP0002723_abnormal_immune_serum | 2.07055758 |
| 28 | MP0005387_immune_system_phenotype | 2.06842234 |
| 29 | MP0001790_abnormal_immune_system | 2.06842234 |
| 30 | MP0001968_abnormal_touch/_nociception | 2.05426925 |
| 31 | MP0002722_abnormal_immune_system | 1.96365533 |
| 32 | MP0000716_abnormal_immune_system | 1.96190944 |
| 33 | MP0002254_reproductive_system_inflammat | 1.95290427 |
| 34 | MP0004510_myositis | 1.92833685 |
| 35 | MP0003705_abnormal_hypodermis_morpholog | 1.92609926 |
| 36 | MP0004859_abnormal_synaptic_plasticity | 1.91436154 |
| 37 | MP0000013_abnormal_adipose_tissue | 1.89913346 |
| 38 | MP0009333_abnormal_splenocyte_physiolog | 1.89405367 |
| 39 | MP0002405_respiratory_system_inflammati | 1.86372694 |
| 40 | MP0003111_abnormal_nucleus_morphology | 1.82125545 |
| 41 | MP0005000_abnormal_immune_tolerance | 1.80702461 |
| 42 | MP0000689_abnormal_spleen_morphology | 1.79692348 |
| 43 | MP0004130_abnormal_muscle_cell | 1.76985390 |
| 44 | MP0003329_amyloid_beta_deposits | 1.73510451 |
| 45 | MP0002429_abnormal_blood_cell | 1.68745234 |
| 46 | MP0000015_abnormal_ear_pigmentation | 1.68425328 |
| 47 | MP0002452_abnormal_antigen_presenting | 1.66641544 |
| 48 | MP0000003_abnormal_adipose_tissue | 1.64899803 |
| 49 | MP0000383_abnormal_hair_follicle | 1.64804804 |
| 50 | MP0004947_skin_inflammation | 1.62936155 |
| 51 | MP0005410_abnormal_fertilization | 1.62374071 |
| 52 | MP0008569_lethality_at_weaning | 1.62314839 |
| 53 | MP0001919_abnormal_reproductive_system | 1.62057874 |
| 54 | MP0001835_abnormal_antigen_presentation | 1.62048092 |
| 55 | MP0003283_abnormal_digestive_organ | 1.61757073 |
| 56 | MP0005025_abnormal_response_to | 1.60712354 |
| 57 | MP0002822_catalepsy | 1.58867374 |
| 58 | MP0002736_abnormal_nociception_after | 1.54265463 |
| 59 | MP0006292_abnormal_olfactory_placode | 1.50336836 |
| 60 | MP0005423_abnormal_somatic_nervous | 1.50158993 |
| 61 | MP0000538_abnormal_urinary_bladder | 1.49533663 |
| 62 | MP0009785_altered_susceptibility_to | 1.40053158 |
| 63 | MP0003656_abnormal_erythrocyte_physiolo | 1.38139243 |
| 64 | MP0003183_abnormal_peptide_metabolism | 1.36984227 |
| 65 | MP0005075_abnormal_melanosome_morpholog | 1.34086419 |
| 66 | MP0004885_abnormal_endolymph | 1.32610397 |
| 67 | MP0002638_abnormal_pupillary_reflex | 1.31555785 |
| 68 | MP0003806_abnormal_nucleotide_metabolis | 1.30856696 |
| 69 | MP0004808_abnormal_hematopoietic_stem | 1.29380732 |
| 70 | MP0006082_CNS_inflammation | 1.22572104 |
| 71 | MP0004145_abnormal_muscle_electrophysio | 1.22053485 |
| 72 | MP0005332_abnormal_amino_acid | 1.21050835 |
| 73 | MP0000470_abnormal_stomach_morphology | 1.17166466 |
| 74 | MP0006072_abnormal_retinal_apoptosis | 1.16940086 |
| 75 | MP0009278_abnormal_bone_marrow | 1.16469492 |
| 76 | MP0004381_abnormal_hair_follicle | 1.15304483 |
| 77 | * MP0003077_abnormal_cell_cycle | 1.15011549 |
| 78 | MP0005377_hearing/vestibular/ear_phenot | 1.12615550 |
| 79 | MP0003878_abnormal_ear_physiology | 1.12615550 |
| 80 | MP0003045_fibrosis | 1.11647220 |
| 81 | MP0005257_abnormal_intraocular_pressure | 1.10106978 |
| 82 | MP0003693_abnormal_embryo_hatching | 1.08884612 |
| 83 | MP0000465_gastrointestinal_hemorrhage | 1.07624356 |
| 84 | MP0001765_abnormal_ion_homeostasis | 1.05885485 |
| 85 | MP0001348_abnormal_lacrimal_gland | 1.05648124 |
| 86 | MP0005310_abnormal_salivary_gland | 1.05619638 |
| 87 | MP0001853_heart_inflammation | 1.05429591 |
| 88 | MP0005394_taste/olfaction_phenotype | 1.03635707 |
| 89 | MP0005499_abnormal_olfactory_system | 1.03635707 |
| 90 | MP0005174_abnormal_tail_pigmentation | 1.03128447 |
| 91 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.02173121 |
| 92 | MP0001958_emphysema | 1.01579716 |
| 93 | MP0003787_abnormal_imprinting | 1.01404777 |
| 94 | MP0005464_abnormal_platelet_physiology | 1.00879645 |
| 95 | MP0001873_stomach_inflammation | 1.00248530 |
| 96 | MP0002735_abnormal_chemical_nociception | 0.96686763 |
| 97 | MP0005397_hematopoietic_system_phenotyp | 0.93702804 |
| 98 | MP0001545_abnormal_hematopoietic_system | 0.93702804 |
| 99 | MP0002419_abnormal_innate_immunity | 0.93468374 |
| 100 | MP0004185_abnormal_adipocyte_glucose | 0.92796565 |
| 101 | MP0008260_abnormal_autophagy | 0.91957015 |
| 102 | MP0000358_abnormal_cell_content/ | 0.89722310 |
| 103 | * MP0003453_abnormal_keratinocyte_physiol | 0.89271394 |
| 104 | MP0003448_altered_tumor_morphology | 0.88911706 |
| 105 | MP0003303_peritoneal_inflammation | 0.88586941 |
| 106 | MP0003724_increased_susceptibility_to | 0.87431440 |
| 107 | MP0005375_adipose_tissue_phenotype | 0.87112224 |
| 108 | MP0003436_decreased_susceptibility_to | 0.87082030 |
| 109 | MP0005389_reproductive_system_phenotype | 0.86532842 |
| 110 | MP0002019_abnormal_tumor_incidence | 0.83054240 |
| 111 | MP0009840_abnormal_foam_cell | 0.82879840 |
| 112 | MP0003300_gastrointestinal_ulcer | 0.82861922 |
| 113 | MP0003137_abnormal_impulse_conducting | 0.82635779 |
| 114 | MP0000604_amyloidosis | 0.82607732 |
| 115 | MP0003091_abnormal_cell_migration | 0.81621206 |
| 116 | MP0010155_abnormal_intestine_physiology | 0.81152961 |
| 117 | MP0001664_abnormal_digestion | 0.80820602 |
| 118 | MP0001845_abnormal_inflammatory_respons | 0.80472529 |
| 119 | MP0005551_abnormal_eye_electrophysiolog | 0.79869464 |
| 120 | MP0002933_joint_inflammation | 0.79538852 |
| 121 | MP0001851_eye_inflammation | 0.78781691 |
| 122 | MP0005365_abnormal_bile_salt | 0.78510143 |
| 123 | MP0009643_abnormal_urine_homeostasis | 0.76796454 |
| 124 | MP0003635_abnormal_synaptic_transmissio | 0.75529143 |
| 125 | MP0002249_abnormal_larynx_morphology | 0.74312857 |
| 126 | MP0008877_abnormal_DNA_methylation | 0.72295685 |
| 127 | MP0010234_abnormal_vibrissa_follicle | 0.72100336 |
| 128 | MP0002132_abnormal_respiratory_system | 0.71403269 |
| 129 | MP0005670_abnormal_white_adipose | 0.70956772 |
| 130 | MP0004197_abnormal_fetal_growth/weight/ | 0.69804395 |
| 131 | MP0010678_abnormal_skin_adnexa | 0.69616186 |
| 132 | MP0004957_abnormal_blastocyst_morpholog | 0.69319620 |
| 133 | MP0005076_abnormal_cell_differentiation | 0.68930972 |
| 134 | MP0003172_abnormal_lysosome_physiology | 0.68824133 |
| 135 | MP0008770_decreased_survivor_rate | 0.68815345 |
| 136 | MP0000955_abnormal_spinal_cord | 0.68526729 |
| 137 | MP0005451_abnormal_body_composition | 0.68513290 |
| 138 | MP0001324_abnormal_eye_pigmentation | 0.68482268 |
| 139 | * MP0000313_abnormal_cell_death | 0.67720508 |
| 140 | MP0000747_muscle_weakness | 0.67697570 |
| 141 | MP0004087_abnormal_muscle_fiber | 0.67578911 |
| 142 | MP0008057_abnormal_DNA_replication | 0.65915736 |
| 143 | MP0010094_abnormal_chromosome_stability | 0.64990169 |
| 144 | * MP0009931_abnormal_skin_appearance | 0.64688495 |
| 145 | MP0000678_abnormal_parathyroid_gland | 0.64466605 |
| 146 | MP0002909_abnormal_adrenal_gland | 0.64226868 |
| 147 | MP0008874_decreased_physiological_sensi | 0.64163940 |
| 148 | MP0004019_abnormal_vitamin_homeostasis | 0.63443930 |
| 149 | MP0002166_altered_tumor_susceptibility | 0.62969262 |
| 150 | * MP0000367_abnormal_coat/_hair | 0.62627318 |
| 151 | MP0008789_abnormal_olfactory_epithelium | 0.62503757 |
| 152 | MP0009384_cardiac_valve_regurgitation | 0.62463579 |
| 153 | MP0000490_abnormal_crypts_of | 0.61846412 |
| 154 | MP0001346_abnormal_lacrimal_gland | 0.60600325 |
| 155 | MP0005253_abnormal_eye_physiology | 0.59734631 |
| 156 | MP0003828_pulmonary_edema | 0.59560561 |
| 157 | MP0000858_altered_metastatic_potential | 0.58024679 |
| 158 | MP0005621_abnormal_cell_physiology | 0.57949690 |
| 159 | MP0005409_darkened_coat_color | 0.57403367 |
| 160 | MP0000467_abnormal_esophagus_morphology | 0.57310796 |
| 161 | MP0004043_abnormal_pH_regulation | 0.57168930 |
| 162 | MP0001502_abnormal_circadian_rhythm | 0.56164304 |
| 163 | MP0005666_abnormal_adipose_tissue | 0.55317145 |
| 164 | MP0001849_ear_inflammation | 0.55227825 |
| 165 | MP0001730_embryonic_growth_arrest | 0.53449264 |
| 166 | MP0000759_abnormal_skeletal_muscle | 0.53240961 |
| 167 | * MP0005501_abnormal_skin_physiology | 0.50789975 |
| 168 | MP0001905_abnormal_dopamine_level | 0.49439238 |
| 169 | MP0002136_abnormal_kidney_physiology | 0.49132395 |
| 170 | MP0002118_abnormal_lipid_homeostasis | 0.47870481 |
| 171 | MP0002210_abnormal_sex_determination | 0.46315659 |
| 172 | MP0004858_abnormal_nervous_system | 0.46182855 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Testicular atrophy (HP:0000029) | 7.47917167 |
| 2 | Rib fusion (HP:0000902) | 6.27720057 |
| 3 | Mesangial abnormality (HP:0001966) | 6.09232134 |
| 4 | Dyschromatopsia (HP:0007641) | 5.84696654 |
| 5 | Attenuation of retinal blood vessels (HP:0007843) | 5.06296094 |
| 6 | Hemorrhage of the eye (HP:0011885) | 4.84951616 |
| 7 | Abnormality of the intrinsic pathway (HP:0010989) | 4.59847091 |
| 8 | Rectal fistula (HP:0100590) | 4.55443044 |
| 9 | Rectovaginal fistula (HP:0000143) | 4.55443044 |
| 10 | Joint hemorrhage (HP:0005261) | 4.52416895 |
| 11 | Annular pancreas (HP:0001734) | 4.47613591 |
| 12 | Facial hemangioma (HP:0000329) | 4.41929980 |
| 13 | Panhypogammaglobulinemia (HP:0003139) | 4.39327276 |
| 14 | Prolonged partial thromboplastin time (HP:0003645) | 4.38567227 |
| 15 | Vaginal fistula (HP:0004320) | 4.38270135 |
| 16 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 4.34373243 |
| 17 | Increased hepatocellular lipid droplets (HP:0006565) | 4.33694548 |
| 18 | Akinesia (HP:0002304) | 4.32807050 |
| 19 | Intestinal fistula (HP:0100819) | 4.31416375 |
| 20 | Facial diplegia (HP:0001349) | 4.23441982 |
| 21 | Popliteal pterygium (HP:0009756) | 4.14843105 |
| 22 | Lipid accumulation in hepatocytes (HP:0006561) | 4.11643189 |
| 23 | Turricephaly (HP:0000262) | 4.10646118 |
| 24 | Renal Fanconi syndrome (HP:0001994) | 4.09497926 |
| 25 | Choroideremia (HP:0001139) | 3.98596395 |
| 26 | T lymphocytopenia (HP:0005403) | 3.98529313 |
| 27 | Aplasia/Hypoplasia involving the carpal bones (HP:0006502) | 3.75430797 |
| 28 | Recurrent fungal infections (HP:0002841) | 3.70688772 |
| 29 | Aplasia of the musculature (HP:0100854) | 3.65978678 |
| 30 | Abnormality of T cell number (HP:0011839) | 3.57097422 |
| 31 | Fetal akinesia sequence (HP:0001989) | 3.54044863 |
| 32 | Delayed epiphyseal ossification (HP:0002663) | 3.52159185 |
| 33 | Squamous cell carcinoma (HP:0002860) | 3.51528568 |
| 34 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 3.46961505 |
| 35 | Atrioventricular block (HP:0001678) | 3.39979863 |
| 36 | Abnormality of the fingertips (HP:0001211) | 3.39339818 |
| 37 | Nasal polyposis (HP:0100582) | 3.33292323 |
| 38 | Coronal craniosynostosis (HP:0004440) | 3.31744985 |
| 39 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.31008898 |
| 40 | Recurrent cutaneous fungal infections (HP:0011370) | 3.31008898 |
| 41 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.30731491 |
| 42 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.29459909 |
| 43 | Recurrent bronchitis (HP:0002837) | 3.26538016 |
| 44 | Anteriorly placed anus (HP:0001545) | 3.24708859 |
| 45 | Chronic otitis media (HP:0000389) | 3.18097286 |
| 46 | Increased intramyocellular lipid droplets (HP:0012240) | 3.17545409 |
| 47 | Increased muscle lipid content (HP:0009058) | 3.16809672 |
| 48 | Hypoalbuminemia (HP:0003073) | 3.15905855 |
| 49 | Abnormal albumin level (HP:0012116) | 3.15905855 |
| 50 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 3.15290599 |
| 51 | Decreased central vision (HP:0007663) | 3.13324137 |
| 52 | Patellar aplasia (HP:0006443) | 3.01526946 |
| 53 | Agammaglobulinemia (HP:0004432) | 2.99060625 |
| 54 | Eczematoid dermatitis (HP:0000976) | 2.98899057 |
| 55 | Abnormality of T cells (HP:0002843) | 2.97763867 |
| 56 | Abnormality of the costochondral junction (HP:0000919) | 2.97285898 |
| 57 | Combined immunodeficiency (HP:0005387) | 2.95883173 |
| 58 | Myotonia (HP:0002486) | 2.95802791 |
| 59 | Severe combined immunodeficiency (HP:0004430) | 2.93724486 |
| 60 | Amniotic constriction ring (HP:0009775) | 2.91936408 |
| 61 | Abnormality of placental membranes (HP:0011409) | 2.91936408 |
| 62 | Recurrent viral infections (HP:0004429) | 2.90041168 |
| 63 | Zonular cataract (HP:0010920) | 2.87873208 |
| 64 | Hyperacusis (HP:0010780) | 2.85177204 |
| 65 | Neonatal onset (HP:0003623) | 2.84826053 |
| 66 | IgM deficiency (HP:0002850) | 2.83489123 |
| 67 | Respiratory difficulties (HP:0002880) | 2.79768951 |
| 68 | Aplasia/Hypoplasia of the patella (HP:0006498) | 2.79108402 |
| 69 | Short chin (HP:0000331) | 2.78871326 |
| 70 | Increased IgE level (HP:0003212) | 2.78593684 |
| 71 | Thin bony cortex (HP:0002753) | 2.73806848 |
| 72 | Exertional dyspnea (HP:0002875) | 2.69362061 |
| 73 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.68825874 |
| 74 | Joint stiffness (HP:0001387) | 2.62537350 |
| 75 | Pustule (HP:0200039) | 2.61899791 |
| 76 | Neonatal respiratory distress (HP:0002643) | 2.60542283 |
| 77 | Capillary hemangiomas (HP:0005306) | 2.59256213 |
| 78 | Cheilitis (HP:0100825) | 2.57686099 |
| 79 | Enlarged epiphyses (HP:0010580) | 2.57043400 |
| 80 | Hypophosphatemic rickets (HP:0004912) | 2.56250812 |
| 81 | Abnormality of the common coagulation pathway (HP:0010990) | 2.55092571 |
| 82 | Supernumerary nipples (HP:0002558) | 2.54923717 |
| 83 | Abnormality of the nasal mucosa (HP:0000433) | 2.53268401 |
| 84 | Thin ribs (HP:0000883) | 2.53232389 |
| 85 | Thrombocytosis (HP:0001894) | 2.52572185 |
| 86 | Insomnia (HP:0100785) | 2.49470689 |
| 87 | Stomatitis (HP:0010280) | 2.49359335 |
| 88 | Widely patent fontanelles and sutures (HP:0004492) | 2.48803086 |
| 89 | Prostate neoplasm (HP:0100787) | 2.46470341 |
| 90 | Myositis (HP:0100614) | 2.46458593 |
| 91 | Colitis (HP:0002583) | 2.42283321 |
| 92 | Acute lymphatic leukemia (HP:0006721) | 2.40181332 |
| 93 | Abnormal number of erythroid precursors (HP:0012131) | 2.38576949 |
| 94 | Abnormal urine phosphate concentration (HP:0012599) | 2.36115507 |
| 95 | Chorioretinal atrophy (HP:0000533) | 2.33199436 |
| 96 | 11 pairs of ribs (HP:0000878) | 2.29735647 |
| 97 | Prominent nose (HP:0000448) | 2.29084144 |
| 98 | Choanal stenosis (HP:0000452) | 2.27010150 |
| 99 | Gastrointestinal inflammation (HP:0004386) | 2.26696467 |
| 100 | Abnormal epiphyseal ossification (HP:0010656) | 2.24338050 |
| 101 | Inflammation of the large intestine (HP:0002037) | 2.24171901 |
| 102 | Abnormality of cells of the erythroid lineage (HP:0012130) | 2.21795532 |
| 103 | Cholelithiasis (HP:0001081) | 2.21604744 |
| 104 | Abnormality of renal resorption (HP:0011038) | 2.19703430 |
| 105 | Absent thumb (HP:0009777) | 2.19442706 |
| 106 | Flat occiput (HP:0005469) | 2.19099240 |
| 107 | Premature graying of hair (HP:0002216) | 2.17944407 |
| 108 | Progressive muscle weakness (HP:0003323) | 2.17863909 |
| 109 | Cellulitis (HP:0100658) | 2.14783986 |
| 110 | Ankle clonus (HP:0011448) | 2.13454436 |
| 111 | Meningitis (HP:0001287) | 2.12132533 |
| 112 | Tented upper lip vermilion (HP:0010804) | 2.11192998 |
| 113 | Diminished movement (HP:0002374) | 2.09085517 |
| 114 | IgG deficiency (HP:0004315) | 2.06933092 |
| 115 | Lymphopenia (HP:0001888) | 2.06584097 |
| 116 | Aplasia/Hypoplasia involving the musculature (HP:0001460) | 2.06008637 |
| 117 | Pterygium (HP:0001059) | 2.05597050 |
| 118 | Abnormality of T cell physiology (HP:0011840) | 2.05045796 |
| 119 | Abnormality of the endocardium (HP:0004306) | 2.04826233 |
| 120 | Heart block (HP:0012722) | 2.04798080 |
| 121 | Ependymoma (HP:0002888) | 2.01779624 |
| 122 | Congenital stationary night blindness (HP:0007642) | 2.01747621 |
| 123 | Malignant hyperthermia (HP:0002047) | 2.01577878 |
| 124 | Abnormal atrioventricular conduction (HP:0005150) | 2.01010489 |
| 125 | Emphysema (HP:0002097) | 2.00496801 |
| 126 | Reticulocytopenia (HP:0001896) | 2.00484496 |
| 127 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.99976085 |
| 128 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.99976085 |
| 129 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.99976085 |
| 130 | Narrow nasal bridge (HP:0000446) | 1.97624711 |
| 131 | Abnormality of eosinophils (HP:0001879) | 1.97223568 |
| 132 | Long clavicles (HP:0000890) | 1.96732753 |
| 133 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 1.96243472 |
| 134 | Pallor (HP:0000980) | 1.93021810 |
| 135 | Hemiplegia (HP:0002301) | 1.92465513 |
| 136 | Epiphyseal stippling (HP:0010655) | 1.91861571 |
| 137 | Mask-like facies (HP:0000298) | 1.91705989 |
| 138 | Albinism (HP:0001022) | 1.89529570 |
| 139 | Granulocytopenia (HP:0001913) | 1.88758847 |
| 140 | Abnormal gallbladder morphology (HP:0012437) | 1.87625691 |
| 141 | Short humerus (HP:0005792) | 1.87536427 |
| 142 | Progressive external ophthalmoplegia (HP:0000590) | 1.87079150 |
| 143 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.86421872 |
| 144 | Mucopolysacchariduria (HP:0008155) | 1.86421872 |
| 145 | Deep palmar crease (HP:0006191) | 1.85644104 |
| 146 | Increased number of teeth (HP:0011069) | 1.85564154 |
| 147 | Entropion (HP:0000621) | 1.85463707 |
| 148 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 1.85296089 |
| 149 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 1.84447490 |
| 150 | Spinal canal stenosis (HP:0003416) | 1.83670096 |
| 151 | Flat cornea (HP:0007720) | 1.82565045 |
| 152 | Lymphoma (HP:0002665) | 1.82229906 |
| 153 | Easy fatigability (HP:0003388) | 1.82180131 |
| 154 | Abnormal number of incisors (HP:0011064) | 1.80576579 |
| 155 | Hypergammaglobulinemia (HP:0010702) | 1.79975527 |
| 156 | Poikiloderma (HP:0001029) | 1.79847793 |
| 157 | Pili torti (HP:0003777) | 1.79800096 |
| 158 | Mediastinal lymphadenopathy (HP:0100721) | 1.79609888 |
| 159 | Reduced subcutaneous adipose tissue (HP:0003758) | 1.78707595 |
| 160 | Papilloma (HP:0012740) | 1.77514916 |
| 161 | Verrucae (HP:0200043) | 1.77514916 |
| 162 | Macular degeneration (HP:0000608) | 1.77235001 |
| 163 | Abnormal rod and cone electroretinograms (HP:0008323) | 1.77009286 |
| 164 | Cystic hygroma (HP:0000476) | 1.74749735 |
| 165 | Leukocytosis (HP:0001974) | 1.74263888 |
| 166 | Myopathic facies (HP:0002058) | 1.73573922 |
| 167 | Chronic sinusitis (HP:0011109) | 1.72929004 |
| 168 | Open mouth (HP:0000194) | 1.72721969 |
| 169 | Birth length less than 3rd percentile (HP:0003561) | 1.71841422 |
| 170 | Hypoplastic pelvis (HP:0008839) | 1.70561607 |
| 171 | Diaphragmatic weakness (HP:0009113) | 1.70456448 |
| 172 | Eosinophilia (HP:0001880) | 1.68754461 |
| 173 | Neoplasm of the oral cavity (HP:0100649) | 1.68747512 |
| 174 | Bronchitis (HP:0012387) | 1.68233968 |
| 175 | Abnormality of homocysteine metabolism (HP:0010919) | 1.68050668 |
| 176 | Homocystinuria (HP:0002156) | 1.68050668 |
| 177 | Bowed forearm bones (HP:0003956) | 1.66996419 |
| 178 | Bowing of the arm (HP:0006488) | 1.66996419 |
| 179 | Bony spicule pigmentary retinopathy (HP:0007737) | 1.66850489 |
| 180 | Ulnar bowing (HP:0003031) | 1.64207460 |
| 181 | Broad palm (HP:0001169) | 1.63749472 |
| 182 | Abnormality of chromosome segregation (HP:0002916) | 1.63558072 |
| 183 | Truncal ataxia (HP:0002078) | 1.62353796 |
| 184 | Basal cell carcinoma (HP:0002671) | 1.60484262 |
| 185 | Overriding aorta (HP:0002623) | 1.59491418 |
| 186 | Recurrent abscess formation (HP:0002722) | 1.59248410 |
| 187 | Increased IgM level (HP:0003496) | 1.58594330 |
| 188 | Retrobulbar optic neuritis (HP:0100654) | 1.58031240 |
| 189 | Optic neuritis (HP:0100653) | 1.58031240 |
| 190 | Large eyes (HP:0001090) | 1.56477954 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP4K1 | 4.54339878 |
| 2 | WNK4 | 3.66209866 |
| 3 | MUSK | 3.53441211 |
| 4 | SRPK1 | 3.41083089 |
| 5 | MAP3K10 | 2.99735212 |
| 6 | TLK1 | 2.75915775 |
| 7 | TXK | 2.56339532 |
| 8 | SIK2 | 2.50662200 |
| 9 | EPHA3 | 2.31399999 |
| 10 | TYK2 | 2.27636743 |
| 11 | SIK1 | 2.17855264 |
| 12 | EEF2K | 2.16927015 |
| 13 | ZAP70 | 1.97342498 |
| 14 | GRK6 | 1.95595142 |
| 15 | STK10 | 1.91143471 |
| 16 | FGFR4 | 1.82239225 |
| 17 | TSSK6 | 1.79093262 |
| 18 | MAPK15 | 1.76754566 |
| 19 | MAP3K13 | 1.71130899 |
| 20 | PRPF4B | 1.65874327 |
| 21 | ITK | 1.55529953 |
| 22 | TRIB3 | 1.54570437 |
| 23 | MAP2K6 | 1.49452180 |
| 24 | DAPK2 | 1.49079515 |
| 25 | PDPK1 | 1.47817829 |
| 26 | BMX | 1.41111884 |
| 27 | IRAK2 | 1.41106488 |
| 28 | MARK2 | 1.38404588 |
| 29 | HIPK2 | 1.37097358 |
| 30 | KIT | 1.36316305 |
| 31 | EPHB1 | 1.35622446 |
| 32 | CCNB1 | 1.35075196 |
| 33 | PDK2 | 1.33812646 |
| 34 | BTK | 1.33101049 |
| 35 | SMG1 | 1.29854409 |
| 36 | CSF1R | 1.28012384 |
| 37 | SCYL2 | 1.26921490 |
| 38 | JAK1 | 1.24641701 |
| 39 | ERN1 | 1.19969392 |
| 40 | TAOK2 | 1.18531825 |
| 41 | LCK | 1.18070378 |
| 42 | BUB1 | 1.15694805 |
| 43 | HCK | 1.15571161 |
| 44 | TESK2 | 1.15390342 |
| 45 | PIM2 | 1.13980246 |
| 46 | BRD4 | 1.12809470 |
| 47 | TAOK1 | 1.12222662 |
| 48 | BLK | 1.05963705 |
| 49 | NLK | 1.05508835 |
| 50 | FES | 1.05075614 |
| 51 | CDK6 | 1.03717168 |
| 52 | SYK | 1.03263474 |
| 53 | KSR2 | 1.00744277 |
| 54 | PTK6 | 1.00561268 |
| 55 | CSK | 0.99694734 |
| 56 | NEK2 | 0.99254679 |
| 57 | JAK3 | 0.96746293 |
| 58 | ZAK | 0.96103320 |
| 59 | MAP3K7 | 0.94902129 |
| 60 | TYRO3 | 0.94688527 |
| 61 | JAK2 | 0.93747901 |
| 62 | PAK1 | 0.92852512 |
| 63 | UHMK1 | 0.92691009 |
| 64 | PRKCH | 0.92226330 |
| 65 | IKBKE | 0.91877839 |
| 66 | AURKA | 0.89338830 |
| 67 | PRKD2 | 0.88934266 |
| 68 | CDK15 | 0.88372060 |
| 69 | TBK1 | 0.87698241 |
| 70 | IRAK4 | 0.87221741 |
| 71 | MAP3K8 | 0.86321714 |
| 72 | CDK11A | 0.85485402 |
| 73 | CDK12 | 0.84127353 |
| 74 | ALK | 0.83592745 |
| 75 | WNK1 | 0.83353776 |
| 76 | IRAK3 | 0.82091123 |
| 77 | PRKD3 | 0.80547607 |
| 78 | CDK18 | 0.80054642 |
| 79 | TTN | 0.79152349 |
| 80 | RPS6KC1 | 0.76714824 |
| 81 | RPS6KL1 | 0.76714824 |
| 82 | ADRBK1 | 0.74050145 |
| 83 | MAP3K11 | 0.73834448 |
| 84 | IKBKB | 0.73765694 |
| 85 | ARAF | 0.73538989 |
| 86 | BCKDK | 0.73420502 |
| 87 | RPS6KA6 | 0.73304555 |
| 88 | CLK1 | 0.71755181 |
| 89 | TNK2 | 0.71366937 |
| 90 | PAK4 | 0.65553989 |
| 91 | EPHA2 | 0.64482715 |
| 92 | MAPK11 | 0.64379889 |
| 93 | MAP3K1 | 0.60696177 |
| 94 | NTRK2 | 0.60252761 |
| 95 | MAP2K3 | 0.59501198 |
| 96 | DMPK | 0.59078020 |
| 97 | MST1R | 0.58393030 |
| 98 | CDK14 | 0.58341557 |
| 99 | ROCK2 | 0.57903529 |
| 100 | PAK6 | 0.55554847 |
| 101 | ICK | 0.55515885 |
| 102 | DYRK1A | 0.55399087 |
| 103 | MAP2K2 | 0.55044334 |
| 104 | NME2 | 0.54178996 |
| 105 | MTOR | 0.54162672 |
| 106 | CAMK1G | 0.53094557 |
| 107 | ACVR1B | 0.52177385 |
| 108 | SIK3 | 0.52128272 |
| 109 | ATR | 0.51759750 |
| 110 | STK16 | 0.50607818 |
| 111 | CSNK1A1L | 0.50167523 |
| 112 | CHUK | 0.49562661 |
| 113 | DYRK1B | 0.48800157 |
| 114 | CDC42BPA | 0.47803688 |
| 115 | CSNK1G3 | 0.47006927 |
| 116 | RPS6KA5 | 0.45553727 |
| 117 | CHEK2 | 0.45410714 |
| 118 | FGFR3 | 0.45215077 |
| 119 | CSNK1G1 | 0.44024687 |
| 120 | MAPK12 | 0.43871490 |
| 121 | MAPK8 | 0.43734228 |
| 122 | STK11 | 0.42772541 |
| 123 | CAMK4 | 0.42765284 |
| 124 | CDK4 | 0.41644330 |
| 125 | RPS6KA2 | 0.41355658 |
| 126 | NTRK3 | 0.41277175 |
| 127 | LYN | 0.40906637 |
| 128 | MATK | 0.40804258 |
| 129 | PKN2 | 0.40191070 |
| 130 | DYRK3 | 0.39563541 |
| 131 | PNCK | 0.38397819 |
| 132 | RIPK1 | 0.38072702 |
| 133 | PRKAA1 | 0.37552060 |
| 134 | CAMK1 | 0.37036894 |
| 135 | PRKD1 | 0.36802752 |
| 136 | RAF1 | 0.34963485 |
| 137 | MELK | 0.33616181 |
| 138 | AKT2 | 0.31454300 |
| 139 | PDK1 | 0.31404039 |
| 140 | TRIM28 | 0.30822056 |
| 141 | ADRBK2 | 0.29822276 |
| 142 | CAMKK1 | 0.29553445 |
| 143 | PRKCI | 0.29302506 |
| 144 | CDK1 | 0.27005264 |
| 145 | RPS6KA1 | 0.26672740 |
| 146 | RIPK4 | 0.25392391 |
| 147 | CDK2 | 0.22359652 |
| 148 | BRAF | 0.22299582 |
| 149 | MAPK3 | 0.20958261 |
| 150 | PLK1 | 0.20831122 |
| 151 | MAP3K3 | 0.18585721 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 7.50691124 |
| 2 | Sulfur relay system_Homo sapiens_hsa04122 | 4.99366316 |
| 3 | Primary immunodeficiency_Homo sapiens_hsa05340 | 4.30031759 |
| 4 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 3.68908453 |
| 5 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 3.46144553 |
| 6 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 3.09446331 |
| 7 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 2.79131002 |
| 8 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 2.60892262 |
| 9 | Other glycan degradation_Homo sapiens_hsa00511 | 2.40235032 |
| 10 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 2.39499373 |
| 11 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.38487178 |
| 12 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 2.25294728 |
| 13 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.21789798 |
| 14 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.94272127 |
| 15 | Ribosome_Homo sapiens_hsa03010 | 1.78705400 |
| 16 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.69684169 |
| 17 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.65444746 |
| 18 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.64176752 |
| 19 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.63124339 |
| 20 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.56532754 |
| 21 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.41352200 |
| 22 | Spliceosome_Homo sapiens_hsa03040 | 1.40348839 |
| 23 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.37964766 |
| 24 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.37405366 |
| 25 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.33514885 |
| 26 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.29246508 |
| 27 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.25561495 |
| 28 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.25102747 |
| 29 | Measles_Homo sapiens_hsa05162 | 1.19597452 |
| 30 | Lysosome_Homo sapiens_hsa04142 | 1.19156103 |
| 31 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.17087474 |
| 32 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.16474102 |
| 33 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.15800052 |
| 34 | HTLV-I infection_Homo sapiens_hsa05166 | 1.15156643 |
| 35 | DNA replication_Homo sapiens_hsa03030 | 1.13908692 |
| 36 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.13532406 |
| 37 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.11509055 |
| 38 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.09845134 |
| 39 | Circadian rhythm_Homo sapiens_hsa04710 | 1.08425285 |
| 40 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 1.08160772 |
| 41 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.04704268 |
| 42 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.02055071 |
| 43 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.01286892 |
| 44 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.99672802 |
| 45 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.98540166 |
| 46 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.97761385 |
| 47 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.95160093 |
| 48 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.89346085 |
| 49 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.89237502 |
| 50 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.88841933 |
| 51 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.88252395 |
| 52 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.86402204 |
| 53 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.85336562 |
| 54 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.84481060 |
| 55 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.83990947 |
| 56 | Long-term potentiation_Homo sapiens_hsa04720 | 0.83942482 |
| 57 | Cocaine addiction_Homo sapiens_hsa05030 | 0.83916248 |
| 58 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.82471228 |
| 59 | Base excision repair_Homo sapiens_hsa03410 | 0.82421314 |
| 60 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.81202305 |
| 61 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.79966523 |
| 62 | Axon guidance_Homo sapiens_hsa04360 | 0.78675046 |
| 63 | Cell cycle_Homo sapiens_hsa04110 | 0.77580122 |
| 64 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.76867295 |
| 65 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.76380106 |
| 66 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.76278117 |
| 67 | Hepatitis B_Homo sapiens_hsa05161 | 0.76276152 |
| 68 | RNA polymerase_Homo sapiens_hsa03020 | 0.75408649 |
| 69 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.74532752 |
| 70 | Endocytosis_Homo sapiens_hsa04144 | 0.72703710 |
| 71 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.72546918 |
| 72 | Apoptosis_Homo sapiens_hsa04210 | 0.72131198 |
| 73 | Colorectal cancer_Homo sapiens_hsa05210 | 0.71891311 |
| 74 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.71834422 |
| 75 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.71597398 |
| 76 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.70547820 |
| 77 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.68899944 |
| 78 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.68709678 |
| 79 | Taste transduction_Homo sapiens_hsa04742 | 0.68611635 |
| 80 | Platelet activation_Homo sapiens_hsa04611 | 0.68271917 |
| 81 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.67866332 |
| 82 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.67322117 |
| 83 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.66557762 |
| 84 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.66231611 |
| 85 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.65653963 |
| 86 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.65583735 |
| 87 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.65398495 |
| 88 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.64146878 |
| 89 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.63515024 |
| 90 | Insulin resistance_Homo sapiens_hsa04931 | 0.63172226 |
| 91 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.62686648 |
| 92 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.61768505 |
| 93 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.61542630 |
| 94 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.60749956 |
| 95 | Lysine degradation_Homo sapiens_hsa00310 | 0.60657367 |
| 96 | Morphine addiction_Homo sapiens_hsa05032 | 0.60466357 |
| 97 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.60172092 |
| 98 | Leishmaniasis_Homo sapiens_hsa05140 | 0.59973744 |
| 99 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.59344680 |
| 100 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.58712204 |
| 101 | Influenza A_Homo sapiens_hsa05164 | 0.55340232 |
| 102 | Salivary secretion_Homo sapiens_hsa04970 | 0.55064114 |
| 103 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.54915941 |
| 104 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.54864336 |
| 105 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.54153245 |
| 106 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.51883969 |
| 107 | Alcoholism_Homo sapiens_hsa05034 | 0.51780569 |
| 108 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.51448324 |
| 109 | Bladder cancer_Homo sapiens_hsa05219 | 0.51359378 |
| 110 | Shigellosis_Homo sapiens_hsa05131 | 0.51174841 |
| 111 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.50951330 |
| 112 | Phototransduction_Homo sapiens_hsa04744 | 0.50653386 |
| 113 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.49914220 |
| 114 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.49891395 |
| 115 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.49518846 |
| 116 | RNA transport_Homo sapiens_hsa03013 | 0.48017336 |
| 117 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.47907871 |
| 118 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.47839532 |
| 119 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.47317502 |
| 120 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.46623331 |
| 121 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.46272669 |
| 122 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.45445093 |
| 123 | Hepatitis C_Homo sapiens_hsa05160 | 0.45321442 |
| 124 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.45289164 |
| 125 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.44666349 |
| 126 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.41132983 |
| 127 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.40688547 |
| 128 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.39446017 |
| 129 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.39262213 |
| 130 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.39012880 |
| 131 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.37150130 |
| 132 | Melanogenesis_Homo sapiens_hsa04916 | 0.35296315 |
| 133 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.33049159 |
| 134 | Galactose metabolism_Homo sapiens_hsa00052 | 0.32081649 |
| 135 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.31537100 |
| 136 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.30138704 |
| 137 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.27122789 |
| 138 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.26663116 |
| 139 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.25797640 |
| 140 | Basal transcription factors_Homo sapiens_hsa03022 | 0.25510139 |
| 141 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.23878315 |
| 142 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.22690587 |
| 143 | Tuberculosis_Homo sapiens_hsa05152 | 0.22311230 |
| 144 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.16599564 |
| 145 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.16011271 |
| 146 | Metabolic pathways_Homo sapiens_hsa01100 | 0.15718898 |
| 147 | Endometrial cancer_Homo sapiens_hsa05213 | 0.15623634 |
| 148 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.14973089 |
| 149 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.14398299 |
| 150 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.11917802 |
| 151 | Gap junction_Homo sapiens_hsa04540 | 0.11149230 |
| 152 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.10191196 |

